Figure 7

Imaging modalities delivery of RNAi therapeutics in cancer therapy and clinical applications

Loutfy H Madkour*

Published: 04 March, 2021 | Volume 5 - Issue 1 | Pages: 005-034

Micro-PET/CT images of nudemice bearingwith HeLa cervical tumor xenografts in the right rear leg at 6 h after intravenous injection of folic acid (F-PEG-HAuNS-siRNA (DOTA-64Cu) or PEG-HAuNS-siRNA (DOTA-64Cu). Tumors were marked by arrowheads. Figure adapted with permission from [133].

" alt="jro-aid1035-g007"class="img-responsive img-rounded " style="cursor:pointer">

Figure 7:

Micro-PET/CT images of nudemice bearingwith HeLa cervical tumor xenografts in the right rear leg at 6 h after intravenous injection of folic acid (F-PEG-HAuNS-siRNA (DOTA-64Cu) or PEG-HAuNS-siRNA (DOTA-64Cu). Tumors were marked by arrowheads. Figure adapted with permission from [133].

Read Full Article HTML DOI: 10.29328/journal.jro.1001035 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?